230 related articles for article (PubMed ID: 26332801)
1. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
[TBL] [Abstract][Full Text] [Related]
2. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
[TBL] [Abstract][Full Text] [Related]
4. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
[TBL] [Abstract][Full Text] [Related]
5. The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission?
Podolakova K; Barak L; Jancova E; Stanik J; Sebekova K; Podracka L
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231246
[TBL] [Abstract][Full Text] [Related]
6. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
[TBL] [Abstract][Full Text] [Related]
7. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
Škrha J; Horová E; Šoupal J; Valeriánová A; Malík J; Prázný M; Zima T; Kalousová M; Škrha J
J Diabetes Complications; 2022 Jul; 36(7):108206. PubMed ID: 35644724
[TBL] [Abstract][Full Text] [Related]
9. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
[TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence and glycemic variability.
Noordzij MJ; Lefrandt JD; Graaff R; Smit AJ
Diabetes Technol Ther; 2010 Jul; 12(7):581-5. PubMed ID: 20597834
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
Forbes JM; Le Bagge S; Righi S; Fotheringham AK; Gallo LA; McCarthy DA; Leung S; Baskerville T; Nisbett J; Morton A; Teasdale S; D'Silva N; Barrett H; Jones T; Couper J; Donaghue K; Isbel N; Johnson DW; Donnellan L; Deo P; Akison LK; Moritz KM; O'Moore-Sullivan T
Sci Rep; 2021 May; 11(1):9422. PubMed ID: 33941808
[TBL] [Abstract][Full Text] [Related]
12. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
Kostolanská J; Jakus V; Barák L
J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
[TBL] [Abstract][Full Text] [Related]
13. Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients.
Yavuz DG; Apaydin T
J Clin Densitom; 2022; 25(3):373-379. PubMed ID: 34933784
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.
de Ranitz-Greven WL; Kaasenbrood L; Poucki WK; Hamerling J; Bos DC; Visser GH; Biesma DH; Beulens JW; de Valk HW
Diabetes Technol Ther; 2012 Dec; 14(12):1134-9. PubMed ID: 23113747
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
[TBL] [Abstract][Full Text] [Related]
16. Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.
Kellow NJ; Coughlan MT; Reid CM
Eur J Nutr; 2018 Sep; 57(6):2209-2216. PubMed ID: 28656390
[TBL] [Abstract][Full Text] [Related]
17. The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.
Maran A; Morieri ML; Falaguasta D; Avogaro A; Fadini GP
Diabetes Care; 2022 Oct; 45(10):2439-2444. PubMed ID: 35972256
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.
Bos DC; de Ranitz-Greven WL; de Valk HW
Diabetes Technol Ther; 2011 Jul; 13(7):773-9. PubMed ID: 21510765
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory.
Ducos C; Rigo M; Larroumet A; Delyfer MN; Korobelnik JF; Monlun M; Foussard N; Poupon P; Haissaguerre M; Blanco L; Mohammedi K; Rigalleau V
Diabetes Metab; 2021 Feb; 47(1):101156. PubMed ID: 32387701
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]